Recent News
Accenture (NYSE: ACN) has agreed to acquire Intellera Consulting, an Italian consultancy firm operating in the public administration and healthcare sectors. The acquisition aligns with Accenture’s ongoing focus on helping Italian public service organizations enhance and transform their citizen services.
Essential Pharma, an international specialty pharma group focused on ensuring that patients have sustainable access to low volume, clinically differentiated, niche pharmaceutical products across key therapeutic areas, announces that it has completed the acquisition of the entire issued share capital of Renaissance Pharma Ltd…
Gyrus Capital S.A. (“Gyrus” or the “Firm”) an investment firm dedicated to investments in the healthcare and sustainability sectors, today announced the final closing of Gyrus Capital Fund II (“Fund II”), raising €310 million and surpassing the €215 million raised for Gyrus Fund I (2021). Fund II consists of the Principal Fund and an open-ended Co-investment vehicle, allowing the Firm to make larger investments. With the close of Fund II, total funds raised since inception (November 2018) exceeds €750 million.
Intellera Consulting acquires Trust4Value (T4V), a company specialized in Data Analytics and Machine Learning services that develops solutions and systems aimed at the collection and analysis of large quantities of data, applying advanced analytical models, to help institutions and businesses take their business decisions.
The acquisition adds the specialized capabilities and deep expertise of the largest U.S. consultancy dedicated to public transport system safety, system security and fire and life safety.
Gyrus Capital and AIS Global are pleased to announce that they have entered into an agreement for Gyrus Capital to acquire LRE Medical, a leading provider of complex devices and analytical instruments for the life sciences industry.
Inflexion and Gyrus Capital are pleased to announce that they have entered into an agreement for Inflexion to acquire a majority stake in dss+…
Gyrus Capital is to acquire Consulcesi Group to build out a pan-European digital platform for the Healthcare industry.
Gyrus Capital to acquire a majority stake in Katalist Group to build out a global software integration platform enhancing the digital transformation of food and pharma distribution.